Quantbot Technologies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,703
Closed -$51.2K 1708
2023
Q2
$51.2K Sell
42,703
-34,843
-45% -$43.4K ﹤0.01% 1319
2023
Q1
$97.7K Buy
+77,546
New +$148K 0.01% 1096
2022
Q4
Sell
-32,301
Closed -$386K 1827
2022
Q3
$386K Buy
32,301
+27,726
+606% +$344K 0.03% 663
2022
Q2
$38K Sell
4,575
-9,226
-67% -$71.5K ﹤0.01% 1352
2022
Q1
$119K Buy
13,801
+1,401
+11% +$13.5K 0.01% 997
2021
Q4
$140K Sell
12,400
-1,000
-7% -$11.9K 0.01% 805
2021
Q3
$168K Buy
+13,400
New +$123K 0.01% 841
2021
Q2
Sell
-1,000
Closed -$9K 1595
2021
Q1
$9K Buy
+1,000
New +$10.1K ﹤0.01% 1255
2020
Q4
Sell
-800
Closed -$9K 1430
2020
Q3
$9K Buy
+800
New +$10.6K ﹤0.01% 1127

Other funds holding GOSS

Quantbot Technologies's GOSS Position: Q3 2023 in Review

Quantbot Technologies sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 42,703 shares — an estimated $51.2K sold.

Quantbot Technologies first reported a position in GOSS in Q3 2020 and held it in 9 quarters. The position peaked at $386K in Q3 2022. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Quantbot Technologies reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Quantbot Technologies sold 42,703 Gossamer Bio shares in Q3 2023, an estimated $51.2K.
  • Quantbot Technologies first reported a position in Gossamer Bio in Q3 2020 and held it in 9 quarters.
  • Quantbot Technologies's Gossamer Bio position peaked at $386K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.